Corneal penetration of fluoroquinolones: Aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops

Journal of Cataract and Refractive Surgery

Volumn 31, Issue 7, 2005, Pages 1377-1385

  Koch, Hans Reinhard ^a   Kulus, Sven C ^a,d   Roessler, Markus ^a   Ropo, Auli ^b   Geldsetzer, Klaus ^c  

^a Hochkreuzklinik Eye Hospital   (Germany)

^b Santen Oy   (Finland)

^c SANTEN PHARMACEUTICAL CO LTD   (Japan)

^d Hochkreuz Augenklinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; LEVOFLOXACIN; OFLOXACIN; OFTAQUIX; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADULT; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA PERFORATION; DILUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THREE DIMENSIONAL IMAGING; AGED; ANTERIOR EYE CHAMBER; CORNEA; HISTOLOGY; METABOLISM; PHACOEMULSIFICATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; ANTERIOR CHAMBER; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; FEMALE; HUMANS; MALE; OFLOXACIN; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION;

EID: 24944536091     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2004.12.063     Document Type: Article

References (12)

1. Davis R, Bryson HM. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 1994; 47:677-700; erratum 1994; 48;132
2. Graves A, Henry M, O'Brien TP, et al. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones. Cornea 2001; 20:301-305; errata, 546
3. Ross DL, Riley CM. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharm 1990; 63:237-250
4. Mitsui Y, Ooishi M, Sasaki K, Ohashi Y. [AQCmax as a pharmacokinetic parameter of ophthalmic solution]. (Japanese) J Eye 1995; 12:783-786
5. Sasaki K, Mitsui Y, Fukuda M, et al. [Intraocular penetration mode of five fluoroquinolone ophthalmic solutions evaluated by the newly proposed parameter of AQC max]. (Japanese) J Eye 1995; 12:787-789
6. Kawazu K, Midori Y, Ota A. Cultured rabbit corneal epithelium elicits levofloxacin absorption and secretion. J Pharm Pharmacol 1999; 51:791-796
7. Kawazu K, Midori Y, Shiono H, Ota A. Characterization of the carrier-mediated transport of levofloxacin, a fluoroquinolone antimicrobial agent, in rabbit cornea. J Pharm Pharmacol 1999; 51:797-801
8. Beck R, van Keyserlingk J, Fischer U, et al. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different topical application modes. Graefes Arch Clin Exp Ophthalmol 1999; 237: 89-92
9. Doft BH. The Endophthalmitis Vitrectomy Study [editorial]. Arch Ophthalmol 1991; 109:487-489
10. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study; the Endophthalmitis Vitrectomy Study Group. Am J Ophthalmol 1996; 122:1-17; correction, 920
11. Pinna A, Sechi LA, Zanetti S, et al. Adherence of ocular isolates of Staphylococcus epidermidis to ACRYSOF intraocular lenses; a scanning electron microscopy and molecular biology study. Ophthalmology 2000; 107: 2162-2166
12. Tanaka M, Otsuki M, Une T, Nishino T. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. J Antimicrob Chemother 1990; 26:659-666